Boston Scientific Recalled Angiographic Catheters
Healthcare providers must halt usage of these devices following reports of tip degradation.
Updated on Sept. 28, 2026 in Healthcare
Live Poll
Do you trust that medical device manufacturers prioritize patient safety over their own manufacturing costs?
Boston Scientific recalled its Imager II Angiographic Catheter product line and permanently discontinued the devices after they were found to be manufactured outside approved specifications. The recall followed two reported serious injuries linked to the catheters.
Why it matters
The defect, caused by inadequate levels of stabilizing agents, created a risk of catheter tips detaching during procedures, leading to potential end-organ failure. The withdrawal forces medical facilities to re-evaluate their current inventory and supply chain reliance.
Two serious injuries were linked to the defect vs. zero reported deaths. The recall encompasses the full product line, following the company's instruction for providers to remove affected stock.
The players
Boston Scientific
A major global medical device manufacturer specializing in less-invasive technologies for a wide range of interventional medical specialties.
The details
Boston Scientific manufactured the Imager II Angiographic Catheters with insufficient stabilizing agents, which allowed the catheter tip to degrade or detach during clinical use. This failure can result in significant procedural delays or severe patient health complications. In response, the company issued an urgent letter to customers mandating that they immediately stop using and distributing all affected units.
Timeline
July 16: Two serious injuries were reported regarding the defect.
August 24: Boston Scientific instructed customers to halt the use and distribution of the catheters.
Market Landscape
This recall demonstrates the operational risks inherent in failing to meet FDA design specification standards. It highlights how manufacturing deviations can trigger immediate product discontinuation and significant supply chain disruptions for medical providers.
Clinical operators should verify their existing catheter inventory against the impacted product list to ensure all units are quarantined and pulled from circulation. Management should audit procurement records to identify alternative suppliers to avoid procedure scheduling gaps.
The takeaway
Manufacturing deviations that bypass approved specifications pose existential risks to product lines and patient safety. Operators should maintain rigorous documentation of equipment inventory to ensure rapid compliance with recall instructions when defects are discovered.
Further reading
For more on industry safety standards, see the Healthcare section.
Source note: This article includes information reported by Benzinga.
Live Poll
Do you trust that medical device manufacturers prioritize patient safety over their own manufacturing costs?
